RxDoctor Payments DataLook up a doctor →

Ari Isaacson, MD

Vascular & Interventional Radiology · Chapel Hill, NCNPI 1982674586

Payments from drug & device makers

$344,541in general payments, 2019–2025

Across 322 payments — averaging $1070.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Terumo Medical Corporation$163K
  • Boston Scientific$114K
  • GE HealthCare$35K
  • Merit Medical Systems Inc$7K
  • Siemens Medical Solutions USA, Inc.$7K
  • Biocompatibles, Inc.$6K
  • plus $12K from 11 others
$87,424in research payments, 2019–2025

Across 2 payments — averaging $43,712 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Terumo Medical Corporation$87K

What the payments were for

  • Consulting fees$256,55288%
  • Speaking & faculty fees$16,8106%
  • Travel & lodging$8,9963%
  • Food & beverage$7,8843%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$344,541 in reported general payments places this provider in the 95th percentile of 106 vascular & interventional radiology providers in North Carolina.

See all vascular & interventional radiology providers in North Carolina

Medicare billing

Part B allowed, 2024
$2,835,023
Medicare patients
387
Services billed
15,173

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone566$3,094
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst280$2,093
Naproxen384$735
Famotidine498$652
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim253$528
Phenazopyridine Hcl98$405
Ciprofloxacin Hcl30$119

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Chapel Hill

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →